119 related articles for article (PubMed ID: 36607383)
1. 68Ga-DOTAGA-IAC PET/CT for Imaging Metastatic and Recurrent Adrenocortical Carcinoma: A Case Series.
Pandey S; Walia R; Kumar R; Chopra S; Rana N; Chatterjee D; Satz S; Mittal BR; Shukla J
Clin Nucl Med; 2023 Feb; 48(2):e95-e98. PubMed ID: 36607383
[TBL] [Abstract][Full Text] [Related]
2. Superiority of 18 F-FDG PET/CT to 68 GA-FAPI PET/CT in Adrenocortical Tumor Imaging.
Kaplan İ; Can C; Kepenek F; Ibiloğlu İ; Güzel Y
Clin Nucl Med; 2023 Jun; 48(6):e307-e309. PubMed ID: 36754357
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT image findings of a dog with adrenocortical carcinoma.
Lee D; Yun T; Koo Y; Chae Y; Chang D; Yang MP; Kang BT; Kim H
BMC Vet Res; 2022 Jan; 18(1):15. PubMed ID: 34980137
[TBL] [Abstract][Full Text] [Related]
5. Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Arora S; Damle NA; Aggarwal S; Passah A; Behera A; Arora G; Bal C; Tripathi M
Clin Nucl Med; 2018 Jun; 43(6):449-451. PubMed ID: 29578871
[TBL] [Abstract][Full Text] [Related]
6. Higher SUV
Wrenn SM; Moore AL; Shah HJ; Barletta JA; Vaidya A; Kilbridge KL; Doherty GM; Jacene HA; Nehs MA
Am J Surg; 2023 Feb; 225(2):309-314. PubMed ID: 36137821
[TBL] [Abstract][Full Text] [Related]
7. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
[TBL] [Abstract][Full Text] [Related]
8. 68 Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma : A Head-to-Head Comparison With 18F-FDG.
Chopra S; Walia R; Mathur Y; Roesch F; Moon ES; Rana N; Pandey S; Chatterji D; Kumar R; Singh H; Mittal BR; Shukla J
Clin Nucl Med; 2023 Apr; 48(4):e173-e175. PubMed ID: 36727882
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F FDG PET/CT demonstration of IVC and right atrial involvement in adrenocortical carcinoma.
Senthil R; Mittal BR; Kashyap R; Bhattacharya A; Radotra BD; Bhansali A
Jpn J Radiol; 2012 Apr; 30(3):281-3. PubMed ID: 22180188
[TBL] [Abstract][Full Text] [Related]
11. Functioning metastasis from adrenocortical carcinoma.
Cunha C; Donato S; Silva T; Leite V
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35078872
[TBL] [Abstract][Full Text] [Related]
12. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
Gust L; Taieb D; Beliard A; Barlier A; Morange I; de Micco C; Henry JF; Sebag F
World J Surg; 2012 Jun; 36(6):1406-10. PubMed ID: 22131094
[TBL] [Abstract][Full Text] [Related]
13. Right Adrenocortical Carcinoma Coexisting With Left Adrenal Sarcomatoid Carcinoma on FDG PET/CT.
Chen H; Dai J; Gao F; Tian R
Clin Nucl Med; 2023 Oct; 48(10):e503-e505. PubMed ID: 37682621
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of adrenal carcinoma.
Gaujoux S; Weinandt M; Bonnet S; Reslinger V; Bertherat J; Dousset B
J Visc Surg; 2017 Oct; 154(5):335-343. PubMed ID: 28754418
[TBL] [Abstract][Full Text] [Related]
15. Bilateral adrenal hypermetabolism with
Márquez Fernández J; Mena Bares LM; Carmona Asenjo E; Maza Muret FR; Moreno Ortega E; Vallejo Casas JA
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(6):383-384. PubMed ID: 34752376
[No Abstract] [Full Text] [Related]
16. 18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease.
Libé R; Jazeron JF; Louiset E; Groussin L
Endocrine; 2019 Jan; 63(1):188-189. PubMed ID: 30251165
[No Abstract] [Full Text] [Related]
17. 68Ga-DOTANOC PET/CT in Multiple Endocrine Neoplasia 1 With Associated Adrenocortical Carcinoma.
Basheer S; Ratheesan R; Sarma M; Palaniswamy SS; Mathews A
Clin Nucl Med; 2022 May; 47(5):e389-e392. PubMed ID: 35195585
[TBL] [Abstract][Full Text] [Related]
18. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
[TBL] [Abstract][Full Text] [Related]
19. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Leboulleux S; Deandreis D; Escourrou C; Al Ghuzlan A; Bidault F; Aupérin A; Travagli JP; Lumbroso J; Schlumberger M; Baudin E
Eur J Endocrinol; 2011 Jan; 164(1):89-94. PubMed ID: 20921280
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET in adrenocortical carcinoma.
Becherer A; Vierhapper H; Pötzi C; Karanikas G; Kurtaran A; Schmaljohann J; Staudenherz A; Dudczak R; Kletter K
Cancer Biother Radiopharm; 2001 Aug; 16(4):289-95. PubMed ID: 11602999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
